Publication | Closed Access

Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial

ThrombosisCardiovascular DiseaseMedicinePhase IiiHematologyIntravascular CoagulationHemostasisPharmacotherapyCoagulopathyPharmacologyAnticoagulant